Cargando…
Patients with irritable bowel syndrome are more burdened by co-morbidity and worry about serious diseases than healthy controls- eight years follow-up of IBS patients in primary care
BACKGROUND: Irritable Bowel Syndrome (IBS) is a hidden public health disease that affects up to 20% of the general population. Although co-morbidity can affect diagnose setting and treatment of the disease, there are few studies concerning diagnosed and registered co-morbidity for IBS patients in pr...
Autores principales: | Faresjö, Åshild, Grodzinsky, Ewa, Hallert, Claes, Timpka, Toomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847157/ https://www.ncbi.nlm.nih.gov/pubmed/24025070 http://dx.doi.org/10.1186/1471-2458-13-832 |
Ejemplares similares
-
Self-Reported Use of Pharmaceuticals Among Patients With Irritable Bowel Syndrome in Primary Care
por: Faresjo, Ashild, et al.
Publicado: (2008) -
Could gastrointestinal disorders differ in two close but divergent social environments?
por: Grodzinsky, Ewa, et al.
Publicado: (2012) -
More negative self-esteem and inferior coping strategies among patients diagnosed with IBS compared with patients without IBS - a case–control study in primary care
por: Grodzinsky, Ewa, et al.
Publicado: (2015) -
Health-related quality of life of irritable bowel syndrome patients in different cultural settings
por: Faresjö, Åshild, et al.
Publicado: (2006) -
Gastrointestinal symptoms - an illness burden that affects daily work in patients with IBS
por: Faresjö, Åshild, et al.
Publicado: (2019)